Use of gabapentin to reduce chronic neuropathic pain in Fabry disease

Author： Ries M.   Mengel E.   Kutschke G.   Kim K.   Birklein F.   Krummenauer F.   Beck M.  

Publisher： Springer Publishing Company

ISSN： 0141-8955

Source： Journal of Inherited Metabolic Disease, Vol.26, Iss.4, 2003-06, pp. : 413-414

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renal disease in Fabry patients

By Grünfeld J.-P.   Lidove O.   Joly D.   Barbey F.  

Journal of Inherited Metabolic Disease, Vol. 24, Iss. 2, 2001-04 ,pp. : 71-74

Springer Publishing Company

Access to resources Recommend Favorite

Gene therapy for Fabry disease

By Sitaskas C.   Medin J.  

Journal of Inherited Metabolic Disease, Vol. 24, Iss. 2, 2001-04 ,pp. : 25-41

Springer Publishing Company

Access to resources Recommend Favorite

Cardiac manifestations in Fabry disease

By Linhart A.   Lubanda J.-C.   Palecek T.   Bultas J.   Karetová D.   Ledvinová J.   Elleder M.   Aschermann M.  

Journal of Inherited Metabolic Disease, Vol. 24, Iss. 2, 2001-04 ,pp. : 75-83

Springer Publishing Company

Access to resources Recommend Favorite

An historical overview of Fabry disease

By Fabry H.  

Journal of Inherited Metabolic Disease, Vol. 24, Iss. 2, 2001-04 ,pp. : 3-7

Springer Publishing Company

Access to resources Recommend Favorite

More about Surfactant and Prevention of Pain and Chronic Lung Disease

By  

Neonatology, Vol. 93, Iss. 4, 2008-06 ,pp. : 281-281

Karger

Access to resources Recommend Favorite